Wells Fargo & Company Hexo Corp. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $0.26 $449 - $686	-2,642 Reduced 85.7%	441 $0
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.61 $1,389 - $4,237	-6,946 Reduced 69.26%	3,083 $1,000
Q1 2022 May 16, 2022	SELL	$0.48 - $0.74 $1,099 - $1,695	-2,291 Reduced 18.6%	10,029 $6,000
Q4 2021 Feb 14, 2022	BUY	$0.7 - $1.94 $1,528 - $4,235	2,183 Added 21.53%	12,320 $8,000
Q3 2021 Nov 15, 2021	SELL	$1.82 - $5.71 $1,767 - $5,544	-971 Reduced 8.74%	10,137 $19,000
Q2 2021 Aug 16, 2021	SELL	$5.22 - $7.33 $1,336 - $1,876	-256 Reduced 2.25%	11,108 $65,000
Q1 2021 May 13, 2021	SELL	$4.0 - $10.28 $2,328 - $5,982	-582 Reduced 4.87%	11,364 $74,000
Q4 2020 Feb 09, 2021	BUY	$2.43 - $4.68 $29,028 - $55,907	11,946 New	11,946 $44,000

23.7K

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.